Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2000
04/06/2000WO2000019185A1 Method for the photometric analysis of test elements
04/06/2000WO2000018970A1 Method for controlling the release of granules
04/06/2000WO2000018968A1 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
04/06/2000WO2000018965A1 Multiplex genotyping using fluorescent hybridization probes
04/06/2000WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000WO2000018960A2 Methods and products related to genotyping and dna analysis
04/06/2000WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000WO2000018958A2 An in vitro activity assay for human hepatits b virus (hbv) dna polymerase, the use of such an assay to assay activity of various serum samples and to screen for inhibitors of the hbv dna polymerase and a method of producing hbv dna polymerase
04/06/2000WO2000018957A1 Methods of nucleic acid amplification and sequencing
04/06/2000WO2000018956A1 Method for dna- or rna-sequencing
04/06/2000WO2000018955A1 Novel method for the preselection of shotgun clones of a genome or a portion thereof of an organism
04/06/2000WO2000018954A2 Use of pex in the treatment of metabolic bone diseases
04/06/2000WO2000018953A1 Method for detecting atp
04/06/2000WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes
04/06/2000WO2000018949A2 Delivery of phosphoinositide polyphosphates into cells
04/06/2000WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
04/06/2000WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000WO2000018902A1 Method of screening for large offspring syndrome
04/06/2000WO2000018899A2 Angiotensin converting enzyme homolog and its use
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018891A1 Fructosamine oxidase assay: methods and materials
04/06/2000WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000WO2000018805A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
04/06/2000WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000WO2000018797A1 Map
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000WO2000018792A1 Solid phase synthesis, whereby the solid phase consists of two different substrates
04/06/2000WO2000018783A1 Mammaglobin, a secreted mammary-specific breast cancer protein
04/06/2000WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000WO2000018599A1 Gas detector for vehicle
04/06/2000WO2000018440A1 Somatostatin receptor radioligand with increased uptake
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018355A2 Use of purified invaplex from gram negative bacteria as a vaccine
04/06/2000WO2000018354A2 Invaplex from gram negative bacteria, method of purification and methods of use
04/06/2000WO2000018351A2 Aglyco products and methods of use
04/06/2000WO2000018298A1 An apparatus and method of measuring the flow of a liquid, in particular urine, from a patient
04/06/2000WO2000018293A1 Diabetes management system and method for controlling blood glucose
04/06/2000WO2000018289A1 Method and device for predicting physiological values
04/06/2000WO2000018238A1 Identification of differentially methylated and mutated nucleic acids
04/06/2000WO2000002031A9 Improved method for mixing and processing specimen samples
04/06/2000WO1999067628A9 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods
04/06/2000WO1999067284A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
04/06/2000WO1999066324A3 A bioluminescence resonance energy transfer (bret) system and its use
04/06/2000WO1999066323A9 Detection of apoptotic cells in living nematodes
04/06/2000WO1999064585A3 Novel angiotensin receptor, production and use thereof
04/06/2000WO1999063347A3 Electrochemical based assay processes, instrument and labels
04/06/2000WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof
04/06/2000WO1999062505A3 Method for treating neurodegenerative disorders
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein
04/06/2000WO1999061453A3 priA
04/06/2000WO1999059608A3 Osteoporosis treatment
04/06/2000WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
04/06/2000WO1999053051A3 5' ests and encoded human proteins
04/06/2000WO1999046657A3 Systems and methods for storing, retrieving, and manipulating data in medical processing devices
04/06/2000WO1999043287A3 Phosphate-based dendrimers for bioassays
04/06/2000WO1999036568A3 Method for identifying t-cell stimulating protein fragments
04/06/2000DE19923567A1 Gene des 1-Desoxy-D-xylulose-Biosynthesewegs Genes of the 1-deoxy-D-xylulose pathway
04/06/2000DE19844315A1 Determination of the anaerobic degradability of organic substances comprises subjecting the substance to a degradation process in a sealed vessel and measuring the pH, redox potential, temperature and gas pressure as a function of time
04/06/2000DE19834808A1 Process to measure the dissolved oxygen content in water gives warning of sensor failure for use in waste water treatment and commercial fish ponds
04/06/2000CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2348548A1 Method for dna- or rna-sequencing
04/06/2000CA2347923A1 Solid phase synthesis with the solid phase consisting of two different substrates
04/06/2000CA2345722A1 Determining resistance to treatment for hepatitis c virus
04/06/2000CA2345532A1 Delivery of phosphoinositide polyphosphates into cells
04/06/2000CA2345066A1 Identifying agents that alter mitochondrial permeability transition pores
04/06/2000CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000CA2344714A1 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells
04/06/2000CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000CA2344575A1 Methods of nucleic acid amplification and sequencing
04/06/2000CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/06/2000CA2344457A1 Slgp protein and nucleic acid molecule and uses therefor
04/06/2000CA2344282A1 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
04/06/2000CA2344274A1 Angiotensin converting enzyme homolog and its use
04/06/2000CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000CA2344104A1 Method of screening for large offspring syndrome
04/06/2000CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers
04/06/2000CA2343965A1 Use of s-ydcb and b-ydcb, essential bacterial genes
04/06/2000CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2343720A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
04/06/2000CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000CA2343357A1 Fructosamine oxidase assay: methods and materials
04/06/2000CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto
04/06/2000CA2341489A1 Somatostatin receptor radioligand with increased uptake
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000CA2306446A1 Methods and products related to genotyping and dna analysis
04/05/2000EP0990904A1 Method for quantitating cholesterol present in low density lipoproteins
04/05/2000EP0990903A1 Biological applications of semiconductor nanocrystals
04/05/2000EP0990902A1 METHOD FOR DETECTING INFECTION WITH ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI)
04/05/2000EP0990901A2 Computer directed identification of paraproteins
04/05/2000EP0990900A2 A method and device for detecting biological elements on a patient, in particular for use in medical - dental surgeries.
1 ... 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 ... 3937